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Seventeen international consortia are collaborating on a human reference atlas (HRA), a
comprehensive, high-resolution, three-dimensional atlas of all the cells in the healthy human
body. Laboratories around the world are collecting tissue specimens from donors varying in
sex, age, ethnicity, and body mass index. However, harmonizing tissue data across 25 organs
and more than 15 bulk and spatial single-cell assay types poses challenges. Here, we present
software tools and user interfaces developed to spatially and semantically annotate (“register”) and explore the tissue data and the evolving HRA. A key part of these tools is a
common coordinate framework, providing standard terminologies and data structures for
describing specimen, biological structure, and spatial data linked to existing ontologies. As of
April 22, 2022, the “registration” user interface has been used to harmonize and publish data
on 5,909 tissue blocks collected by the Human Biomolecular Atlas Program (HuBMAP), the
Stimulating Peripheral Activity to Relieve Conditions program (SPARC), the Human Cell Atlas
(HCA), the Kidney Precision Medicine Project (KPMP), and the Genotype Tissue Expression
project (GTEx). Further, 5,856 tissue sections were derived from 506 HuBMAP tissue blocks.
The second “exploration” user interface enables consortia to evaluate data quality, explore
tissue data spatially within the context of the HRA, and guide data acquisition. A companion
website is at https://cns-iu.github.io/HRA-supporting-information/.
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he National Institutes of Health funded HuBMAP consortium was formed in 2018 to develop an open and global
platform to map the estimated 37 trillion healthy cells in
the human body1,2. An essential component of this platform are
two software programs whose user interfaces enable organ experts
to “register” tissue data and researchers to “explore” tissue data in
a spatially and semantically explicit manner within the context of
the evolving human atlas. The software programs are open and
generalizable; and, they have been adopted by other international
consortia mapping the human body. By combining and harmonizing datasets from these different consortia, the software
is facilitating the collaborative construction of a consensus
human reference atlas (HRA), which will be more accurate and
more complete than would possible using data from only one
consortium.
However, constructing an HRA that captures macro to
microanatomy of healthy adults down to the single-cell level
poses diverse challenges3. First, specimen metadata collected by
different laboratories for diverse donors (e.g., basic demographics
such as sex and age) and different assay types (e.g., spatial
transcriptomics4,5 or CO-Detection by indEXing (CODEX)6 and
associated data provenance) needs to be harmonized so they can
be cross-searched. Second, biological structure data (i.e., information on what anatomical or histological structures and cell
types are present in a tissue blocks extracted from human organs
for interrogation) needs to be collected in a standard manner.
Third, the spatial size of the tissue block, along with the position
and rotation of the block in relation to reference organs positioned in a common three-dimensional (3D) reference space,
need to be recorded.
To address these challenges, the registration and exploration
user interfaces leverage a common coordinate framework (CCF),
which is a “spatiotemporal computational framework for the
management, integration, and analysis of anatomically and spatially indexed data”7. It creates “an underlying reference map of
organs, tissues, or cells that allows new individual samples to be
mapped to determine the relative location of structural regions
between samples”8. In 2017, NIH organized a CCF meeting9
which reviewed different atlas construction projects. The Allen
Mouse Brain Atlas10 was highlighted as a successful example of
combining large-scale mapping, quantiﬁcation, analysis, and
visualization of data. Brain atlas projects identify anatomic-scale
landmarks (e.g., speciﬁc brain folds, speciﬁc lumens with cerebrospinal ﬂuid, or major arteries) that are conserved between
individuals and apply mathematical coordinate mappings to
register data from individual donor tissue samples to a reference
geometry, allowing direct comparison across individuals. In
particular, the Talairach and the Montreal Neurological Institute
Hospital stereotaxic space emerged as CCFs for human brain
tissue. For rodent brains, tThe Paxinos’ Rat brain stereotaxic
coordinate system and Waxholm space11,12 are widely used13–17.
However, a CCF that works for the brain18 does not necessarily
work for other human organs that might be much larger (large
intestine), in/deﬂated (lung), or highly variable in size (lymph
nodes). Therefore, we constructed a CCF for the human reference
atlas (called CCF-HRA) which combines expert-curated ontologies for specimen, biological structure, and spatial data19.
Results
Tissue registration user interface (RUI). Groups contributing
tissue data to advance the HRA need an effective means to register their data within a well-deﬁned 3D spatial reference system
and derive anatomical structure (AS) annotations. Speciﬁcally,
they need to select the most appropriate reference organ (e.g., the
male right kidney if this is the organ from which tissue was
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extracted) and specify the size, position, and rotation of a tissue
block in relation to that organ. They must be able to review the
listing of automatically assigned anatomical structure annotations
and make changes as needed (add or delete annotations) to
describe what anatomical regions the tissue block captures.
The Registration User Interface (RUI), available at https://
hubmapconsortium.github.io/ccf-ui/rui, supports the registration
of tissue data extracted either as tissue blocks or via biopsies. It
allows RUI users to document the tissue extraction site in relation
to a 3D reference organ. Note that RUI users have different
background and expertise, e.g., the six individuals who collectively, registered more than 5000 tissue blocks comprise one
computational biologist/clinician, one biomedical researcher/
basic science researcher, one clinician, one basic science
researcher, one biomedical/basic science/clinician, and one
information scientist.
The RUI web interface lets users enter metadata such as their
name; next, they select an organ from the 3D Reference Object
Library20. Using the 3D interface, they then deﬁne the size of a
virtual tissue block and its position via drag-and-drop (in yellow
in Fig. 1a) inside a reference organ. Collision detection (the
intersection of bounding volumes detected by an algorithm; see
anatomical structures that make up the kidney reference in
Fig. 1b) is used to assign anatomical structure annotations (or
“tags”, see lower right of Fig. 1a). If tissue sections are cut from a
tissue block, it is important to keep track of the z-stack of tissue
sections and their spatial relationships to the tissue block (see
Fig. 1c). A user can deﬁne common tissue extraction sites (see
Fig. 1d) and assign these to multiple tissue samples extracted
from that same site (see Usage of the RUI and EUI section). For
example, 138 GTEx tissue blocks were sampled from female
donors between the ages of 21 and 70 years (mean: 53.2 years)
from the very same extraction site in the left ventricle of the heart.
Some 3D reference objects have ‘Landmarks’ that help organ
experts register tissue (e.g., see ‘bisection line’ for kidney in
Fig. 1a). Previously registered tissue blocks can be made visible to
guide the registration of new tissue blocks (e.g., to register blocks
that were cut adjacent to an already registered tissue block).
Tissue exploration user interface (EUI). The Exploration User
Interface (EUI), available at https://portal.hubmapconsortium.
org/ccf-eui, was implemented for two types of stakeholders: Tissue data providers and tissue data and human reference atlas data
users. (1) Tissue data providers can use the EUI to check and
approve tissue size, location, rotation, and semantic annotations
for the tissue blocks they registered with the RUI and the proper
interlinkage of these tissue blocks with derivative datasets. RUI
registrations are submitted via the HuBMAP Ingest Portal, processed on the backend, and then become available in the EUI for
review and approval (see detailed steps in SOP: Using the CCF
RUI 20). (2) Tissue and atlas data users come to the EUI to ﬁlter,
browse, and search for tissue and atlas data using specimen,
anatomical structures, or spatial data queries. Speciﬁcally, users
expressed interest in running queries such as: What cell types are
located_in which anatomical structure? What cell types/anatomical structures are in 1 mm distance from cell x? Which biomarkers characterize a certain cell type in a speciﬁc anatomical
structure or functional tissue unit (FTU, deﬁned as the smallest
tissue organization that performs a unique physiologic function)?
How many cells of type y are in anatomical structure of type x?
How does the cell type population for the very same region (e.g., a
set of anatomical structures) differ across sex, age, or ethnic
groups? Plus, there is a strong interest in running spatial queries
across donors or assay types, such as: For the same 1 mm3 in a
reference body (e.g., the female body), what tissue blocks exist for
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Fig. 1 Tissue Registration User Interface (RUI). a Tissue registration for kidney using the RUI. b Named anatomical structures that together make up the
male right kidney reference object. c Relationship of cutting plane (in green) to x-y-z coordinate system (red, green, blue axes) of the 3D tissue block are
shown on left. Details panel on the right-hand side of the EUI with information on what tissue sections exist for a tissue block (blue lines in strip plot) and
green-red axes on the left and bottom side of each thumbnail. d Common tissue extraction sites used by three different consortia for the male heart (six
sites for HCA in red, 10 sites for HuBMAP in blue, 25 sites for SPARC in green).

a donor population (e.g., 25–30-year-old females) and/or a speciﬁc assay type (e.g., CODEX data)? Given a tissue block, what
other tissue blocks exist for that same 3D volume?
The current EUI supports exploration of anatomical structures and cell types predicted via organ-speciﬁc ASCT+B
tables19. It uses a split-screen interface (see Figs. 2 and 3c): A
hierarchical list of anatomical structures (e.g., “kidney: cortex”)
on the left is linked to anatomically correct 3D reference objects
in the middle. A listing of cell types commonly found inside these
anatomical structures can be seen in the lower left. The data for
these listings come from the Biological Structure and Spatial
Ontologies in the CCF-HRA. A list of registered tissue blocks
corresponding to the selected anatomical structures is displayed
on the right, with white 3D blocks placed within the reference
organs to indicate the sizes, positions, and rotations of those
tissue blocks. The CCF-HRA Specimen Ontology deﬁnes ﬁlters at
the top left of the user interface for patient demographics, assay
types, and tissue providers.
Usage of the RUI and EUI. The CCF-HRA metadata and associated 3D Reference Object Library are unique in that they
interlink specimen, biological structure, and spatial data in support of HRA construction and usage. The RUI and EUI use the
CCF-HRA to describe collected tissue blocks and biopsies in a

standardized way which enables data harmonization across consortia, donors, organs, and assay types (see Fig. 3).
The RUI requires about ﬁve minutes of training time and two
minutes for each tissue registration21. As of April 2022, 5909
tissue blocks have been collected, including 506 by HuBMAP3, six
by HCA, and 5397 by GTEx22,23. 5856 tissue sections were
derived from the 506 HuBMAP tissue blocks. The resulting data
covers 16 organs with 12 organs featured by HuBMAP (see HRA
Dashboard in Supplementary Fig. 1). While all HuBMAP RUI
locations are linked to tissue block samples in the HuBMAP Data
Portal, RUI locations from SPARC24 and KPMP25 point to
papers; GTEx RUI locations lead the user to the GTEx data
portal.
Note that there is a difference between RUI locations
(modeled as ‘extraction sets’ in the CCF-HRA Spatial Ontology) and tissue blocks in that one RUI location can be assigned
to many tissue blocks. For example, GTEx needed to deﬁne only
29 RUI locations across 13 organs to spatially register 5397
tissue blocks. RUI locations are deﬁned via a RUI JSON ﬁle with
metadata about the creator and the colliding anatomical
structures as well as geometric information about the tissue
block, such as 3D size, position, and rotation. An exemplary
RUI JSON ﬁle is shown in Supplementary Fig. 3 and on Git
Hub at https://cns-iu.github.io/HRA-supporting-information/
rui_registration.json.
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Fig. 2 Tissue Exploration User Interface (EUI). The EUI features an anatomical structure “partonomy” on top left (occluded by ﬁlter menu, but see Fig. 3c)
and a listing of unique cell types in lower left; 3D reference organs with registered tissue blocks (in white) and one selected skin tissue block in upper left
leg (in orange) in middle; and details on all ﬁltered tissue blocks, sections, and datasets on right–the selected skin tissue block has 26 tissue sections, each
section has associated datasets. Filters for specimen metadata are provided in top left (sex, age, BMI, assay types, tissue providers). They are accessible via
a ﬁlter menu; ﬁlter for sex has been set to 'Male.' Registered tissue blocks can be explored via specimen data, biological structure terms, or spatially using
the 3D reference organ framework.

Fig. 3 Workﬂow. a Tissue data (blocks or biopsies) are secured by different laboratories/projects from different donors and organs. b Three different
ontologies capture specimen, biological structure, and spatial metadata derived from organ-speciﬁc ASCT+B tables and 3D reference objects. c The RUI
(top) is used to register tissue data while the EUI (bottom) supports ontologically and spatially explicit exploration of tissue and HRA data across organs,
donors, laboratories, and consortia.
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The average size of the 506 HuBMAP tissue blocks is 13.8 mm
width, 15.2 mm height, and 9.2 mm depth. Exactly 62 tissue
blocks have associated scRNAseq gene biomarker data from
which cell type annotations can be derived using Azimuth26 or
similar services; 90 datasets use validated antibody panels that
detect well deﬁned protein biomarkers and the cell types those
characterize—supporting cell type identiﬁcation at the single-cell
level and are spatially explicit, e.g., they use CODEX6 or Cell
DIVE27, making it possible to run segmentation algorithms at the
anatomical structure, FTU, or single-cell level. Other datasets use
Imaging Mass Spectrometry28, Sequential Fluorescence In-Situ
Hybridization (seqFISH)29, Slide-seq30, or Visium5. Examples of
spatially explicit datasets are the six HCA heart tissue blocks31,
the 19 RUI-registered kidney tissue blocks, or the 12 skin tissue
blocks. GTEx23 is an example of having multiple datasets from
the same extraction sites, as deﬁned by their standard operating
procedures (SOPs)32.
An additional important use case for the RUI and EUI is to
evaluate the coverage and quality of the HRA to inform future
tissue data acquisition and analysis. Single-cell analysis is costly
(e.g., scRNAseq data costs about $1 per cell; sampling a tissue
block of 1 mm3 ﬁlled with 10 μm diameter cells costs about $1
million). Smart data sampling is needed to arrive at data that
captures not only key anatomical structures of single organs but
also the diversity of healthy male and female adults. The CCFHRA and the presented user interfaces make it possible to
compare the coverage of data across projects, as illustrated in the
HRA Dashboard (see Supplementary Fig. 1), which can be
explored interactively at https://hubmapconsortium.github.io/
hra-data-dashboard.
Discussion
The RUI and EUI were released in May 2021 with continuous
updates following. Since then, they have been adopted by six
consortia contributing data toward the HRA. Both user interfaces
are available as web components, which have been successfully
integrated in the HuBMAP portal and rebranded for the GTEx33
and SenNet portals34,35. The CCF-HRA’s three ontologies have
been fully implemented for 25 organs. They enable the RUI and
EUI to capture (1) specimen metadata about the donor (the
“who”); (2) biological structure data, which describes “what” part
of the body a tissue sample came from and details AS, CT, and
biomarkers of the tissue sample; and (3) spatial data, which
indicates “where” a tissue sample is located in a shared 3D
common coordinate system.
Limitations. Known limitations for the RUI include a limited set
of reference organs (25 currently) with comparatively large anatomical structures and a not yet adressed need to scale tissue
blocks based on size differences between the donor organ and the
reference organ. In addition, manipulating the 3D position and
rotation of virtual tissue blocks in a 3D scene inside a 2D browser
can be challenging, especially for users with little or no experience
with 3D tools. However, recent work has shown that new RUI
users can register a tissue block, taking on average 22.6 seconds
per block and achieving a 5.9 degrees rotation and 1.32 mm
position accuracy after around 8 tasks in the series of 30 identical
tasks21.
Known limitations for the current EUI include limited ﬁlters
and no deep linking capabilities. We run informal user studies for
3D spatial search and this new functionality became available in
July 2022. Long loading times due to the increasing number of 3D
reference organs and registered tissue blocks have been addressed
in a recent release of the EUI that decreases loading times by a
factor of 10.

ARTICLE

While the CCF-HRA is a work-in-progress, the current data
structures and user interfaces demonstrate the entire workﬂow
from human tissue acquisition and registration via the RUI to
data representation and exploration within the EUI for a
rigorously deﬁned and standardized data registration and
management process. We are sharing this ﬁrst CCF-HRA
implementation to build awareness of our work and to obtain
feedback and suggestions from the broader community, including
other efforts that aim to map the human body at single-cell
resolution. In addition, we seek feedback from scientists who are
interested in using HRA data for their research, integrating CCFHRA user interfaces into their workﬂows, and/or incorporating
CCF-HRA data structures and user interfaces into their portals.
Next steps. The ultimate goal of this effort is to develop effective
means to interlink and federate new and existing data across
scales (from anatomical structures, to cell types to biomarkers)
and to link the evolving HRA to existing ontologies and 3D
references. This will make it possible to understand and communicate the spatial organization of the human body across
scales; interpret new datasets in the context of the evolving CCFHRA (e.g., support cell type label transfer as done by Azimuth26);
and map tissue blocks spatially based on their unique morphology and molecular “ﬁngerprint” (e.g., given scRNA-seq data for a
new tissue block, this block can be mapped into the 3D space that
has a similar cell-type population with comparable biomarker
expression values).
New datasets, technologies, and user requirements will both
demand and make possible continuous improvements of the 3D
reference object library and ontologies, the registration, mapping,
and exploration processes, and the user interfaces. The CCF-HRA
and associated user interfaces are expected to evolve to support
ever more robust and detailed registration and exploration of
semantically and spatially annotated tissue data.
Developing a CCF-HRA for the human body is a major
undertaking that requires access not only to high-quality and
high-coverage data but also to human expertise across both
biological and technological domains. It seems highly desirable to
develop and agree on data formats across consortia and to
develop data infrastructures and user interfaces that empower
many users to contribute to the construction and usage of a HRA.
Serving as a “rosetta stone,” the ASCT+B tables help translate
and federate data across organs and let many experts contribute.
A user interface like the RUI makes it possible to register tissue
samples spatially and semantically in a uniform manner in
support of cross-consortium exploration via the EUI.
Experts interested in joining this international effort are invited
to register via the survey at https://iu.co1.qualtrics.com/jfe/form/
SV_bpaBhIr8XfdiNRH to receive regular updates and invites to
relevant meetings that aim to advance the construction and usage
of an HRA.
Methods
CCF-HRA Specimen Ontology and data. CCF-HRA Specimen Ontology
describes the demographic, clinical, and other metadata associated with human
specimen tissue samples. The complete HuBMAP clinical data—covering more
than 100 metadata ﬁelds—was reduced to a smaller set of metadata ﬁelds that are
relevant for CCF-HRA construction and usage. CCF-HRA specimen data was then
compared with data made available by other consortia to ﬁnalize data ﬁelds relevant for CCF-HRA design. The current CCF-HRA specimen data includes
demographics and clinical data (e.g., sex, age, body mass index [BMI]), workﬂow
information (e.g., tissue sample creation/modiﬁcation date, donor/organ/tissue ID,
specimen/data/assay type), author information (e.g., author group/creator), and
links to source data/publications. Additional components of the CCF-HRA specimen data link samples to the laboratories (tissue mapping centers [TMCs] in
HuBMAP) and projects that collected the tissue, and assay types (e.g., CODEX,
Periodic acid–Schiff, or autoﬂuorescence). Note that for HuBMAP data, specimen
information is created on the ﬂy by querying the HuBMAP search-API. For data
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Fig. 4 Semantic and Spatial Representation of a Kidney. a The CCF Biological Structure Ontology represents the body as a set of nested, named
anatomical structures (the anatomical structures “partonomy”) and cell types (the cell type “typology”). Anatomical structures and cell types are linked to
Uberon/FMA and CL ontologies respectively, and are mapped to 3D reference objects at macro to single-cell level. b The CCF Spatial Ontology leverages
the 3D Reference Object Library to deﬁne the dimensions and shapes of ASCT+B entities within the HRA 3D space (called the ‘Atlas reference system’).
The male and female VHP reference bodies are registered within the HRA space. All organ reference objects are registered to the respective male or
female VHP reference body. A new tissue block is sized, positioned, and rotated relative to a reference organ. Segmentation masks for single cells and
functional tissue units identiﬁed via manual or automatic means are spatially registered with their respective tissue section images–z-stacks of 2D tissue
sections make up 3D tissue blocks.
from other consortia, specimen information is stored in the rui_locations.jsonld
ﬁle for each tissue block.
The complete set of specimen data consists of data collected during data
ingestion and data generated during tissue registration using the RUI. Data is
shared in JSON with the following 22 ﬁelds: donor ID (de-identiﬁed), age (or age
range), sex, BMI (kg/m2), consortium name, tissue provider name, tissue provider
UUID, tissue provider author, links to source data, tissue block ID, tissue block
dimensions (width, height, depth, and unit of measurement), tissue block
position (called translation) and tissue block rotation (both relative to the 3D space
shared with the CCF-HRA reference organ), tissue block placement author,
number of tissue sections (for a given tissue block), size of tissue sections (including
units of measurement), tissue section ID, tissue section number, dataset ID, dataset
technology used, dataset assay type, and dataset thumbnail.

CCF-HRA Biological Structure Ontology and data. In addition to registration
and exploration user interfaces, the user requirements assessment identiﬁed the
need for agreement across multiple consortia and stakeholders on what anatomical
structures, cell types, and biomarkers are relevant for construction and usage of an
HRA. The biomarkers include cell type-speciﬁc genes, proteins, lipids, and metabolites commonly used to characterize cell types that are located in speciﬁc anatomical structures. Collectively, we call this the ASCT+B terminology.
Furthermore, anatomical structures and cells exist in a 3D context, and there is a
need for 3D representations of major anatomical structures and cell types so that
experimental data can be spatially registered, explored, and analyzed in the context
of this 3D HRA.
A parallel effort by 17 consortia19 is therefore creating (1) ASCT+B data tables
that capture major anatomical structures, cell types, and biomarkers and their
interrelationships—including part_of relations (the hierarchical “partonomy”)
between anatomical structures, located_in relations between cell types
and anatomical structures, and characterizes relationships between biomarkers and
cell types, and (2) associated 3D reference objects that represent the size, position,
6

rotation, and shape of major anatomical structures that are listed in the ASCT+B
tables. While organs differ substantially in their form and function and across
human specimens, all have anatomical structures, cell types, and biomarkers that
are captured in the ASCT+B tables and the associated 3D Reference Object
Library36. The resulting ASCT+B tables represent expert knowledge and
information from textbooks, scholarly publications, and experimental data
evidence. An associated 3D Reference Object Library captures the anatomically
correct 3D shapes, sizes, locations, and rotations of key anatomical structures
present in the ASCT+B tables. The organs are developed by specialist 3D medical
illustrators, and they are approved by organ experts37. Please see Fig. 4a for an
exemplary partial ASCT+B table and corresponding 3D reference objects of a
kidney.
The SOP for ASCT+B table authoring details this process38. In short,
anatomical structure, cell type, and biomarker names are compiled with their
unique identiﬁers in existing ontologies, such as Foundational Model of Anatomy
(FMA)39–41, Uber-anatomy ontology (Uberon)42, Cell Ontology (CL)43, and
Human Genome Nomenclature Committee (HGNC)44 in machine readable,
computable format. Note that the existing ontologies have tens of thousands of
terms, many of which are not relevant for healthy human adults (e.g., terms for
capturing development and growth, cross-species comparisons, and disease). By
authoring the ASCT+B tables, we have discovered omissions in existing ontologies
that need to be resolved to properly represent healthy human adults. In these cases,
we are working closely with the respective ontology curators to add these terms and
corresponding literature justiﬁcations to the ontologies so they properly represent
the HRA. The resulting CCF-HRA Biological Structure Ontology exclusively
captures terms relevant for healthy human adults. An ASCT+B Table Reporter
website was built to visualize the CCF-HRA biological structure data
(Supplementary Fig. 2). It facilitates the construction and review of the ASCT+B
tables by domain experts and enables new users of the RUI and EUI to explore and
become familiar with the data.
In December 2021, 25 ASCT+B tables and 50 associated reference organs were
published, Digital Object Identiﬁers (DOIs) were minted, and all ﬁles were made
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publicly available45. In addition, the ASCT+B tables were published using
Semantic Web technologies in Web Ontology Language (OWL 2)46. The
CCF.OWL was deposited in BioPortal47 and the EMBL-EBI Ontology Lookup
Service (OLS) [cite https://www.ebi.ac.uk/ols/ontologies/ccf], both support version
control. Counts of the number of entities and relationships for the 25 organs can be
found in Supplementary Table 1. For example, the ASCT+B for the kidney features
61 anatomical structures, 62 cell types, and 150 biomarkers, but also 62 part_of
relationships between these anatomical structures, 60 located_in relationships from
cell types to anatomical structures, and 257 characterize relationships from
biomarkers to cell types.
Using the CCF.OWL, the 3D reference objects of the HRA (but also tissue
blocks registered into them) are compatible with and can be linked to other
ontologies and the data they describe. For example, anatomical structures or genes
can be linked to chemical compounds in the ChEMBL48–50, Chemical Entities of
Biological Interest (ChEBI)51,52 or diseases using the Disease Ontology53 and
Human Phenotype Ontology (HPO)54–58.
CCF-HRA Spatial Ontology and data. CCF-HRA spatial Ontology describes the
2D and 3D shapes of entities and their physical size, shape, location, and rotation—
from the whole-body level down to single cells (Fig. 4b). There are three key
concepts to make this work: (1) A Spatial Entity represents a real-world object (e.g.,
a human body, a human kidney, a tissue block or section, or an individual cell). It
deﬁnes a bounded Cartesian space and its unit of measurement. By using the
ccf_representation_of property, we say that a Spatial Entity is representing/standing
in for either an ASCT+B term in the CCF-HRA Biological Structure Ontology or a
physical object, such as a tissue sample. Spatial Entities connect to ASCT+B terms
using either ccf_representation_of or ccf_annotation. (2) A Spatial Object Reference
points to an object in the CCF-HRA Reference Object Library36. It provides a
reference to an external representation of a Spatial Entity, such as a 3D object ﬁle
(e.g., in OBJ, FBX, GLTF format) or a 2D image (e.g., in TIFF, PNG, SVG format).
Initially, most of the anatomically correct 3D reference organs in this library are
created using male and female data from the Visible Human Project (VHP) made
available by the National Library of Medicine59–61. (3) A Spatial Placement deﬁnes
how to place a Spatial Entity or Spatial Object Reference relative to another Spatial
Entity using scaling, rotation, and translation (in that order). Note that rotation (in
x, y, z order) occurs around the center of the object’s coordinate space; by default,
rotation is considered in Euler order. In the case of Spatial Object References, it
deﬁnes how to transform a 2D or 3D object so that it ﬁts the Spatial Entity’s
dimensions and unit of measurement. In the case of Spatial Entities, it shows how
to place one Spatial Entity relative to another.
A unique feature of the CCF-HRA is the interlinkage of the ASCT+B to the 3D
Reference Organs. A Crosswalk table62 links anatomical structures in the ASCT+B
tables to anatomical structures in the 3D organ ﬁle. Given this interlinkage of
ontology terms and 3D nested objects, new forms of semantic and spatial queries
can be supported. For example, given a registered tissue block, the 3D anatomical
structures it contains/collides with can be determined and used as annotations;
using these annotations, all smaller anatomical structures and cell types inside of
larger, colliding anatomical structures can be retrieved. The crosswalked data also
makes it possible to use cell types in search queries and to retrieve all anatomical
structures that typically contain a set of cell types. Plus, it makes it possible to query
for and display all cell types that are in a given set of selected anatomical structures
or tissue blocks, see listing of unique cell types in lower left of Fig. 2.
3D object scene graphs are created using spatial entities, spatial object
references, and spatial placements. Spatial entities and spatial object references are
placed relative to other spatial entities to create a 3D scene graph for use in the RUI
and EUI.
In addition to the 3D Reference Objects, 3D spatial entities are created for
extraction sites and tissue blocks. In general, each tissue block has a well-deﬁned
extraction site in relation to a well-deﬁned 3D Reference Object. In addition, we
capture segmentation masks for FTUs for 2D tissue sections using a GeoJSON data
format.
3D extraction sites and landmarks. In support of systematic tissue extraction across
human donors, many laboratories/projects sample tissue using well deﬁned
“extraction sites.” Each extraction site deﬁnes the size, location, and rotation of a
tissue block in relation to a reference organ, along with a set of anatomical
structure annotations derived via collision detection (see sample in Fig. 1a). Given a
new tissue sample, a previously deﬁned extraction site can be used as metadata. The
RUI makes it easy to deﬁne an extraction site. For example, for the heart, 6
extraction sites have been identiﬁed for HCA, 10 for HuBMAP, 25 for SPARC (see
Fig. 1d), and 2 for GTEx (not shown in Fig. 1d). The process of deﬁning extraction
sites is captured in an SOP63. Named landmarks are available in GLB and FBX
format and are saved with the female and male reference organs64. Further, the
GLB ﬁles are semantically tagged and linked into the CCF-HRA Ontology
(CCF.OWL) via the JSON-LD data.
3D tissue blocks. Using the RUI, metadata can be generated for tissue blocks. All
data can be inspected, corrected, and downloaded in JSON format (see example
data ﬁle in Supplementary Fig. 3). Note that anatomical structure annotations
(‘ccf_annotations’) are provided using Personalized Uniform Resource
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Locator (PURL) links to Uberon terms. ‘Scaling’ indicates how much to shrink
or expand a tissue block and is deﬁned as a ratio. ‘Translation’ captures how to
translate a SpatialEntity (e.g., a tissue block) so that it is placed relative to
another SpatialEntity (e.g., a reference organ) and it is rounded to 1 micrometer
precision. In some cases, tissue sections are cut from a tissue block. RUI users
can enter information on tissue section thickness under ‘slice_thickness,’ which is
given in micrometers. The number of RUI locations publicly available for
HuBMAP tissue blocks can be accessed in the HRA Dashboard (Supplementary
Fig. 1).
3D segmentation masks. We distinguish three types of annotated segmentation
masks: anatomical structure, functional tissue unit (FTU), and single-cell masks.
Exemplary masks were compiled for and used in the “HuBMAP - Hacking the
Kidney” Kaggle competition65. The anatomical structures and FTU masks are
modiﬁed GeoJSON ﬁles that capture the outline of annotations by their pixel
coordinates, and they were generated from annotations by subject matter experts
using QuPath66. Supplementary Fig. 4 shows a GeoJSON ﬁle that describes one
glomerulus mask for a kidney tissue section. The yellow highlighted part lists the 15
x, y location pairs of the 14 line segments that comprise the polyline which outlines
the one glomerulus shown on the right.
Biological structure annotation via collision detection. When a tissue sample, such
as a kidney tissue block, is registered and annotated through the RUI, it is assigned
a unique identiﬁer (e.g., “UUID-S-5678”) using the CCF-HRA Specimen Ontology.
It is linked to a term in the CCF-HRA Biological Structure Ontology, indicating the
anatomical structures or cell type (e.g., “kidney cortex”). The CCF-HRA Biological
Structure Ontology’s anatomical structure partonomy details how the sample ﬁts
within larger structures, up to the whole body. Using the CCF-HRA Spatial
Ontology, samples are linked to a Spatial Entity (e.g., “UUID-SE-9123”), which
gives its size/dimensions. A Spatial Placement (e.g., “UUID-SP-4567”) positions the
sample relative to another Spatial Entity (e.g., “#VHKidneyVH_M_right_kidney”).
After proper registration, all colliding objects are identiﬁed and corresponding
anatomical structure terms from the ASCT+B tables are assigned to the tissue
block as “ccf_annotations.” Further, experts are able to verify and add or remove
anatomical structure terms while registering.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All data are open and free to access.
The ASCT+B tables and associated 3D reference objects for 25 organs published in the
second CCF-HRA release v1.1 are available at the CCF-HRA Portal, https://
hubmapconsortium.github.io/ccf.
Registration data for HuBMAP, SPARC, HCA, KPMP, and GTEx are available at
https://portal.hubmapconsortium.org/ccf-eui. For HuBMAP data, tissue blocks link to
sample and donor metadata and raw data. For all other data, the blocks link to relevant
papers or datasets in the SPARC, HCA, KPMP, and GTEx data portals.
All existing ASCT+B tables can be downloaded from https://hubmapconsortium.
github.io/ccf/pages/ccf-anatomical-structures.html.
Organs in the CCF-HRA 3D Reference Object Library are available as GLB ﬁles at
https://hubmapconsortium.github.io/ccf/pages/ccf-3d-reference-library.html. Further,
these GLB ﬁles are semantically tagged and linked into the CCF-HRA Ontology
(CCF.OWL) via the JSON-LD data format.

Code availability
The registration and exploration user interfaces, standard operating procedures, and
video demos of proper usage of both user interfaces are available via the CCF-HRA
Portal, https://hubmapconsortium.github.io/ccf.
Code is publicly hosted at GitHub https://github.com/hubmapconsortium/ccf-ui. The
Python script used to compute sizes of the 506 HuBMAP tissue blocks is at https://
github.com/cns-iu/HRA-supporting-information.
The RUI is available via the HuBMAP Ingest Portal at https://ingest.
hubmapconsortium.org/ and as a stand-alone67 web application. There is also an SOP for
the RUI20.
Standard operating procedures, demonstrations, learning modules, and self quizzes
exist in the Visible Human MOOC at https://expand.iu.edu/browse/sice/cns/courses/
hubmap-visible-human-mooc.
The CCF-HRA v1.6 source code repository is available at http://purl.org/ccf/source.
The CCF-HRA v1.6 consists of three main parts: (1) The CCF-HRA Core Model is an
architecture for modeling 2D and 3D spatial data annotated with ontology terms. (2) The
CCF-HRA Spatial Reference System is a curated and annotated instantiation of the Core
Model covering the entire scale from the human body down to the single-cell level. (3)
The CCF-HRA Anatomical Structures Partonomy is a curated partonomy using existing
ontology terms which mirrors the CCF-HRA Spatial Reference System.
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The CCF-HRA ontology has been deﬁned as a formal ontology. Data are added as
RDF/XML or JSON-LD that is translated to RDF/XML.
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